Aclarion (ACON) stock: insider trades, news & valuation
Health Care · Strong buyingShare price and insider trades
Aclarion insider trading at a glance (Oct 9, 2026): in the past 12 months, 6 insiders bought $159K and 0 sold $0 of ACON stock on the open market, including a cluster buy that began Aug 13, 2026.
Get emailed when insiders cluster-buy stocks like ACON
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
ACON insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | $126K | 6 | — | 0 |
| Q2 2026 | $51K | 4 | — | 0 |
| Q1 2026 | — | 0 | — | 0 |
| Q4 2025 | $62 | 1 | — | 0 |
Valuation, profit and volume
Summary
Over the past 12 months, 6 Aclarion, Inc. insiders reported open-market purchases totaling $159K, while 0 insiders reported sales totaling $0. The most recent cluster buy began on Aug 13, 2026, when 5 insiders bought a combined $121K.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Aug 19SEC | Amanda M WilliamsDirector | Buy | 5,85725,857 held (+29%) | $2.73 | $16K | -14.3% | — |
| Aug 18SEC | Gregory A GouldCFO | Buy | 10,00060,000 held (+20%) | $2.45 | $24K | -4.5% | — |
| Aug 17SEC | Ryan BondDirector | Buy | 21,12276,122 held (+38%) | $2.37 | $50K | -1.3% | — |
| Aug 17SEC | David K NealDirector | Buy | 7,50030,002 held (+33%) | $2.40 | $18K | -2.5% | — |
| Aug 17SEC | Brent NessCEO | Buy | 5,234111,534 held (+5%) | $2.31 | $12K | +1.3% | — |
| Aug 17SEC | William WesemannDirector | Buy | 2,15023,713 held (+10%) | $2.34 | $5K | +0.0% | — |
| May 12SEC | Scott BreidbartDirector | Buy | 5,664new position | $3.18 | $18K | -26.4% | — |
| May 12SEC | David K NealDirector | Buy | 2,5002,502 held (+125000%) | $3.10 | $8K | -24.5% | — |
| May 11SEC | Brent NessCEO | Buy | 6,2896,300 held (+57173%) | $3.18 | $20K | -26.4% | — |
| May 8SEC | William WesemannDirector | Buy | 1,5621,563 held (+156200%) | $3.30 | $5K | -29.1% | — |
| Dec 1SEC | Brent NessCEO | Buy | 1011 held (+1000%) | $6.20 | $62 | -62.3% | — |
Insiders at Aclarion, Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Ryan BondDirector | $50K | — | Aug 17, 2026 | — |
| Brent NessCEO | $32K | — | Aug 17, 2026 | — |
| David K NealDirector | $26K | — | Aug 17, 2026 | — |
| Gregory A GouldCFO | $24K | — | Aug 18, 2026 | — |
| Scott BreidbartDirector | $18K | — | May 12, 2026 | — |
| Amanda M WilliamsDirector | $16K | — | Aug 19, 2026 | — |
| William WesemannDirector | $10K | — | Aug 17, 2026 | — |
Insider activity at other Health Care companies
Same sector, ranked by insider buying in the last 90 days.
ACON stock: common questions
Are Aclarion, Inc. insiders buying ACON stock?
In the past 12 months, 6 insiders reported open-market purchases of ACON worth $159K. The latest was Director Amanda M Williams bought $16K of ACON at $2.73 — first open-market purchase in our records; raises the stake by 29%.
Are Aclarion, Inc. insiders selling ACON stock?
0 insiders reported sales worth $0 over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is ACON's 52-week range?
Over the past year ACON has traded between $2.02 and $9.69. It last closed at $2.34 on Oct 9, 2026.